Anixa Biosciences Inc. (ANIX)
ANIX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.67
-5.99% on the day
Market cap
$92.8M
Micro cap
Revenue · 2024
$210K
0.0% on 2023
Net income · 2024
-$12.6M
-5978.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | ANIX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000715446 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $210K |
| Net income | -$12.6M |
| Operating income | -$13.8M |
| Net margin | -5978.1% |
| Operating margin | -6586.2% |
| Revenue growth | 0.0% |
| Cash | $1.1M |
| Total assets | $18.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 442.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-09-10 |
| Latest annual report | 10-K | 2026-01-12 |
| Latest quarterly / interim | 10-Q | 2026-09-09 |
| Latest current report | 8-K | 2026-03-11 |
| Latest proxy | DEF 14A | 2026-01-28 |
Source: SEC EDGAR submissions feed, 980 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc. | $4.78 | -9.30% | $92.5M |
| RTSN | Retension Pharmaceuticals Inc. | $11.63 | +2.74% | $91.7M |
| IMUX | Immunic Inc. | $6.89 | -13.33% | $94.0M |
| BMEA | Biomea Fusion Inc. | $1.26 | -7.35% | $91.3M |
| OKUR | OnKure Therapeutics Inc. | $2.35 | -3.10% | $95.0M |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | $0.7658 | -4.93% | $95.3M |
| PLYX | Polaryx Therapeutics Inc. | $1.94 | -3.48% | $96.7M |
| RLYB | Rallybio Corporation | $16.72 | -0.42% | $88.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier